Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

15.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.9K
Ligand Binding Sites02:40

Ligand Binding Sites

9.2K
9.2K
Conserved Binding Sites01:49

Conserved Binding Sites

5.3K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.3K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

15.7K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.7K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

2.2K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human angiotensin‑converting enzyme 2‑specific benzothiazole-based allosteric inhibitor against pan‑sarbecoviruses.

Nature communications·2026
Same author

The Open Molecular Software Foundation (OMSF) and the Growing Role of Open Source Software in Molecular Modeling.

Journal of chemical information and modeling·2026
Same author

In Search of Beautiful Molecules: A Perspective on Generative Modeling for Drug Design.

Journal of chemical information and modeling·2025
Same author

AKR1C3 enhances radioresistance in esophageal adenocarcinoma via inhibiting ferroptosis through suppressing TRIM21-mediated ubiquitination of HSPA5.

Cell death & disease·2025
Same author

A novel approach for first-in-human dose selection using population dose-response modelling to find a minimum anticipated biological effect level.

British journal of clinical pharmacology·2025
Same author

Non-Markovian Dynamic Models Identify Non-Canonical KRAS-VHL Encounter Complex Conformations for Novel PROTAC Design.

JACS Au·2024

Related Experiment Video

Updated: Apr 20, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.7K

Exploring conformational search protocols for ligand-based virtual screening and 3-D QSAR modeling.

Daniel Cappel1, Steven L Dixon, Woody Sherman

  • 1Schrödinger GmbH, Dynamostr. 13, 68165, Mannheim, Germany.

Journal of Computer-Aided Molecular Design
|November 20, 2014
PubMed
Summary

Generating accurate 3-D ligand conformations is crucial for drug design. This study shows that while virtual screening is less sensitive to conformation search methods, 3-D QSAR models benefit significantly from thorough sampling and a novel common scaffold alignment approach.

More Related Videos

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

2.1K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.6K

Related Experiment Videos

Last Updated: Apr 20, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.7K
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

2.1K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.6K

Area of Science:

  • Computational Chemistry
  • Drug Design
  • Cheminformatics

Background:

  • Ligand-based drug design relies on 3-D ligand conformations for methods like pharmacophore modeling and QSAR.
  • Existing conformational search methods often prioritize reproducing crystal structures, not optimal alignment for modeling.

Purpose of the Study:

  • To evaluate the impact of different conformation generation modes on virtual screening and QSAR predictions.
  • To develop and assess a new 'common scaffold alignment' method for improved ligand-based modeling.

Main Methods:

  • Studied various conformation generation modes of ConfGen.
  • Applied methods to virtual screening (Shape Screening, e-Pharmacophore) and QSAR (atom-based, field-based) predictions.
  • Developed and implemented a novel common scaffold alignment search strategy.

Main Results:

  • Virtual screening outcomes showed low sensitivity to conformational search protocols.
  • More extensive conformational sampling generally improved 3-D QSAR prediction accuracy.
  • The common scaffold alignment method significantly enhanced QSAR predictions by focusing sampling.

Conclusions:

  • For virtual screening, computationally efficient conformation generation methods are adequate.
  • Thorough conformational sampling and the common scaffold alignment are vital for accurate 3-D QSAR model building.
  • The developed alignment strategy optimizes ligand-based modeling by reducing noise from non-scaffold regions.